New Review article on PI3K inhibitors!

Klaus has written a review article with his former postdoc supervisor and long-time collaborator Bart Vanhaesebroeck (UCL), along with Matthew Perry (AstraZeneca) , Jennifer Brown (Dana Farber) and Fabrice André (Gustave Roussy). This is a comprehensive review on the development and use of PI3K inhibitors, several of which are now clinically approved drugs.
PI3K inhibitors are finally coming of age
Bart Vanhaesebroeck, Matthew W. D. Perry, Jennifer R. Brown, Fabrice André & Klaus Okkenhaug
Nature Reviews Drug Discovery (2021)
DOI: 10.1038/s41573-021-00209-1
Free download